ProstaFlow Disclaimer: What This Website Does And Does Not Claim

ProstaFlow is a dietary supplement. In the United States that is a defined category with its own rules, and the rules are different from the ones that govern medicines in ways that are worth understanding before buying anything on this shelf.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Those two sentences appear at the foot of every page on this website, on the label itself, and here.

Every row is read from the printed label, the seller's page, or the general position for the category. None of it is specific to this desk's opinion of the product.

Two lines, both from the seller's page and both deliberately general: prostate comfort, and wellness related to concerns often linked to prostate health.

Read plainly, the first is a structure and function statement about a part of the body and the second is closer to a description of the audience the product is sold to. Neither names a symptom, a measurement or a timescale, and neither promises a change in anything countable.

This desk does not enlarge them. It does not add a number, a timeframe or a symptom to either line, and it does not describe the product as science-backed, because the ingredients have research behind them and the finished capsule has none of its own. The benefits page takes both claims apart in detail, and the dosage section sets every printed amount against the amount its own trials used.

What would let this website say more is short and specific: a trial of this finished capsule, at these amounts, in the people it is sold to, measuring something a validated questionnaire can capture, against a comparison group, with the protocol registered before it ran and the result published either way. None of those six is unreasonable and none is present, which is ordinary for the category and is the reason the ceiling is where it is.

Naming them is more useful than a general disclaimer, because a general disclaimer tells a reader nothing about which specific hope they arrived with is unsupported.

Where those subjects appear anywhere on this website, it is to point at a clinician or to state that this desk does not offer them.

The six are listed together because a reader who came looking for one of them is better served by seeing it named than by a page that quietly omits it. A general disclaimer saying results may vary leaves every one of those hopes intact; naming them removes the ambiguity, which costs this desk something and is worth it. The 2026 AUA guideline describes what an initial assessment involves, part two covers medical management, and the US Preventive Services Task Force covers the screening question, which is separate from all of it.

This is the section this page exists for, and it is the one piece of advice on this website that has nothing to sell.

Urinary symptoms have several possible causes and they do not all have the same answer. MedlinePlus sets out the common ones in plain English, and the StatPearls chapter covers the same ground in clinical detail. Being assessed once replaces a guess with an answer, and it changes what is worth doing next more than any capsule can.

Two further points belong here rather than scattered through the site. Anyone taking a nitrate medicine or a PDE5 inhibitor should raise this product with their prescriber before the first capsule, because arginine and citrulline feed the same pathway those medicines work through, and the trial that measured the combination recorded a substantial fall in blood pressure. And the label's own caution rules out anyone under 18, anyone pregnant or nursing, and asks anyone under a clinician's care to raise it first.

A good deal can also be done without anybody's permission, and it is worth more than anything on this panel. A randomised trial put a structured behavioural programme against standard care and the benefit was still there at twelve months; a review by the same authors lists what the programme contains. Every item on that list is free.

• A retail desk. Prostaflowformula is the u.s. stocking partner for prostaflow and earns money when somebody orders, which is stated on the about page as well as here.
• Not the manufacturer, and not North Scale. The label is distributed by North Scale, PO Box 12730, Ogden, UT 84404 and manufactured in the USA with globally sourced ingredients.
• Not a medical service, a clinic or a laboratory. No assay has been run on any bottle by this desk and no certificate is published.
• Not an independent review site. It sells the product it writes about, and the sensible test of that is how much of this website argues against a purchase.
• Not the order desk. The website address holds no order data and cannot start a refund.
• Not the author of an invented expert. The byline on every page is the ProstaFlow Team, an editorial desk with a written method, because inventing a named medical reviewer is the commonest fabrication in this category.

The fourth of those is the one worth testing rather than believing. Count how much of this website argues against a purchase: the dosage comparison, the seal audit, the list of six ingredients this panel does not carry, the note that the seller's own usage advice outruns its own refund window. All of it sits on the pages a buyer reaches before the checkout rather than behind it.